David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
IMAX
IMAX
$2.89B
| $3.48M | ﹤0.01% |
231,484
+109,959
| +90% | +$1.88M |
|
2077
nVent Electric
NVT
$25.1B
| $3.48M | ﹤0.01% |
58,838
-24,218
| -29% | -$1.28M |
|
2078
National Beverage
FIZZ
$3.09B
| $3.48M | ﹤0.01% |
69,925
+14,329
| +26% | +$686K |
|
|
AAMI
2079
Acadian Asset Management
AAMI
$3.39B
| $3.47M | ﹤0.01% |
181,122
+75,543
| +72% | +$1.33M |
|
2080
Southern Copper
SCCO
$180B
| $3.47M | ﹤0.01% |
43,959
-145,463
| -77% | -$10M |
|
2081
Archer Aviation
ACHR
$4.54B
| $3.46M | ﹤0.01% |
+563,935
| New | +$3.2M |
|
2082
Trip.com Group
TCOM
$28.4B
| $3.46M | ﹤0.01% |
96,125
-535,945
| -85% | -$18.3M |
|
|
WIRE
2083
CALL
DELISTED
Encore Wire Corp
WIRE
| $3.46M | ﹤0.01% |
16,200
-3,900
| -19% | -$743K |
|
2084
BrightView Holdings
BV
$1.02B
| $3.45M | ﹤0.01% |
410,299
+64,702
| +19% | +$493K |
|
|
FITB
2085
PUT
Fifth Third Bancorp
FITB
$50B
| $3.45M | ﹤0.01% |
100,000
| – | – |
|
2086
Navient
NAVI
$879M
| $3.45M | ﹤0.01% |
185,112
-100,010
| -35% | -$1.74M |
|
2087
Medifast
MED
$137M
| $3.44M | ﹤0.01% |
51,238
+389
| +0.8% | +$27.1K |
|
2088
Sociedad Química y Minera de Chile
SQM
$22.4B
| $3.44M | ﹤0.01% |
57,165
-7,715
| -12% | -$408K |
|
2089
Coherent
COHR
$57.6B
| $3.44M | ﹤0.01% |
79,041
-264,976
| -77% | -$9.55M |
|
2090
Sun Life Financial
SLF
$44B
| $3.44M | ﹤0.01% |
66,354
-112,717
| -63% | -$5.55M |
|
2091
Arlo Technologies
ARLO
$1.41B
| $3.44M | ﹤0.01% |
361,334
-129,013
| -26% | -$1.18M |
|
2092
PUT
Robinhood
HOOD
$97.6B
| $3.44M | ﹤0.01% |
+270,000
| New | +$2.68M |
|
2093
Goosehead Insurance
GSHD
$2.53B
| $3.44M | ﹤0.01% |
45,377
+26,685
| +143% | +$1.93M |
|
2094
PUT
Organon & Co
OGN
$3.62B
| $3.44M | ﹤0.01% |
+238,400
| New | +$3.24M |
|
2095
AnaptysBio
ANAB
$1.72B
| $3.43M | ﹤0.01% |
160,326
+14,434
| +10% | +$249K |
|
|
TRUE
2096
DELISTED
TrueCar
TRUE
| $3.43M | ﹤0.01% |
992,460
-62,537
| -6% | -$159K |
|
2097
Manulife Financial
MFC
$71.7B
| $3.43M | ﹤0.01% |
155,140
-92,000
| -37% | -$1.77M |
|
2098
Voyager Therapeutics
VYGR
$213M
| $3.43M | ﹤0.01% |
406,044
-220,079
| -35% | -$1.6M |
|
2099
CALL
Symbotic
SYM
$5.27B
| $3.41M | ﹤0.01% |
+66,400
| New | +$2.91M |
|
2100
CALL
Rio Tinto
RIO
$170B
| $3.4M | ﹤0.01% |
45,700
-288,900
| -86% | -$19.4M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.